Received Nov 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | 1 | 3052996 | IM / RA |
| FLU3 | INFLUENZA (SEASONAL) (FLUBLOK) | SANOFI PASTEUR | 1 | U8790AA | IM / LA |
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 945663 | IM / LA |
When I administered the hepatitis vaccine to the patient, I noticed that his eyes rolled upward and his skin became pale. I immediately laid him down on the ground, elevated his legs using a chair, and kept them raised. He did not regain consciousness right away. I checked his breathing, which was normal, and then checked his pulse, which was also normal. I prepared the EpiPen for administration, but at that moment he regained consciousness and started talking. He was sweating heavily. I kept him in the same position for several minutes and continued to monitor his pulse, which remained stable. He declined an ambulance. I asked him to remain in the pharmacy for 30 minutes, and we provided him with a drink. After about 30 minutes, he was able to walk out of the pharmacy on his own. A follow-up call was made later in the afternoon, and he reported that he was doing well
n/a
n/a
n/a
n/a